Treatment of Rheumatic Diseases in Türkiye

Rheumatology is not limited to joint pain. Immune-mediated rheumatic diseases may affect the skin, eyes, lungs, heart, kidneys, nervous system and blood vessels as well as joints and the spine. Mechanical pain, infection, crystal arthritis and autoimmune disease can look alike, so the condition must be classified before treatment is selected.

The NHS guide to arthritis describes many different types of arthritis and advises against self-diagnosis when unexplained pain, swelling or stiffness persists. A “rheumatology panel,” one MRI scan or a brief examination cannot confirm or exclude every rheumatic disease.

Clinicly Health Tourism is an international health-tourism facilitator authorised by the Ministry of Health of the Republic of Türkiye. It can help transfer records to an appropriate rheumatologist and, when needed, other specialists; coordinate communication with the healthcare provider, interpreting, travel and accommodation; and support follow-up after the patient returns home. Diagnosis, tests, medicines, procedures and surgery are decided by licensed clinicians who assess the patient. Clinicly does not replace an examination or an independent second opinion.

Urgent warning: A suddenly painful, hot and swollen single joint with fever may be a joint infection and needs urgent assessment. New chest pain, marked breathlessness, coughing blood, fainting, sudden weakness or speech difficulty, severe new headache, loss of vision, very low or dark urine, widespread bruising, a severe allergic reaction, or high fever while taking an immunosuppressive medicine should not wait. Call 112 in Türkiye or attend an emergency department. These problems are not suitable for planned medical travel.

Conditions commonly assessed

Fibromyalgia, regional soft-tissue pain, osteoporosis and muscle disorders may also be assessed in rheumatology. Fibromyalgia is a real disorder of pain processing, but it is not the same as structural joint inflammation and is not treated with immunosuppression.

Preparing for the first assessment

1. Record when symptoms began, which joints are involved, how long morning stiffness lasts and how activity changes the pain.

2. Note fever, weight change, rash, psoriasis, dry eyes or mouth, mouth ulcers, eye redness, bowel or urinary symptoms and pregnancy plans.

3. Send previous clinic letters, laboratory reports, imaging reports and the original image files where possible.

4. List current and previous medicines, doses, duration, benefit, adverse effects and the reason each was stopped.

5. Report tuberculosis or hepatitis exposure, recurrent infection, vaccination records, surgery, cancer and relevant family history.

6. Describe daily function, sleep, walking tolerance, work or caring duties and the goals that matter to you.

Do not stop glucocorticoids, methotrexate, a biologic or a JAK inhibitor, skip doses or take a treatment “holiday” before travel unless the prescribing clinician gives a plan.

Diagnosis and measurement of disease activity

History and examination

The rheumatologist examines swollen and tender joints, range of motion, the spine and sacroiliac region, and relevant skin, nail, eye, mouth, muscle, nerve and vascular findings. The pattern may suggest inflammatory, mechanical, neuropathic or widespread pain. Standard measures can combine examination, laboratory results, function and the patient’s perspective to monitor activity.

Blood and urine tests

ESR and CRP can indicate inflammation, but normal results do not always exclude active disease. Rheumatoid factor and anti-CCP contribute to a rheumatoid arthritis assessment; neither is a diagnosis by itself. ANA may be positive in healthy people. When lupus is suspected, it is interpreted with symptoms, blood count, urine, kidney function, complement and more specific antibodies. HLA-B27 alone does not diagnose spondyloarthritis.

Blood count, liver and kidney tests and other monitoring are chosen for medicine safety. Urine testing is particularly important in lupus and vasculitis because blood or protein may be an early sign of kidney involvement.

Joint fluid and imaging

Sampling fluid from a suddenly swollen joint can be crucial to distinguish infection, gout crystals and other causes. Finding crystals does not automatically exclude a simultaneous infection. Suspected septic arthritis requires prompt drainage and antimicrobial planning.

X-rays show structural change, ultrasound can show synovitis and tendon disease, and MRI can identify early inflammation and soft-tissue findings. CT is used for selected bone or lung questions, while bone-density scanning helps assess fracture risk. An imaging finding must be interpreted alongside symptoms and examination.

Organ and infection assessment

Depending on the problem, testing may include an eye examination, lung function and CT, ECG or echocardiography, urine protein measurement, nerve studies, capillaroscopy or biopsy. Before biologic or targeted synthetic treatment, tuberculosis, hepatitis and other infection risks are screened according to the person’s history and planned medicine.

Main treatment approaches

Disease-modifying antirheumatic drugs

Conventional disease-modifying medicines such as methotrexate, hydroxychloroquine, leflunomide or sulfasalazine may be used in rheumatoid arthritis, psoriatic arthritis and selected connective-tissue diseases. Choice depends on the diagnosis, organ involvement, reproductive plans, liver and kidney function, infection risk and previous response. Benefit may take time, and regular clinical and laboratory monitoring is essential.

The aim is not only less pain but, where achievable, remission or low disease activity. The American College of Rheumatology clinical guideline centre brings together evidence-based guidance on rheumatoid arthritis, lupus, gout, vasculitis, osteoarthritis, juvenile arthritis, vaccination and reproductive health.

Biologic and targeted synthetic treatments

Biologic medicines targeting pathways such as TNF, interleukins or B cells, and targeted synthetic medicines such as JAK inhibitors, may be appropriate for selected patients. Selection is personalised according to disease type and severity, prior treatments, tuberculosis and hepatitis risk, cancer or clot history, cardiovascular risk, bowel or eye involvement and pregnancy plans.

The “strongest” drug is not automatically the best drug. The plan should state what to do during an infection, around surgery, for vaccination and laboratory monitoring. Combining biologic medicines without specialist direction can be unsafe.

Glucocorticoids, pain medicines and injections

Glucocorticoids can act quickly during some flares, but the lowest effective dose for the shortest feasible period is preferred. Longer exposure can increase infection, glucose, blood pressure, cataract, muscle weakness and osteoporosis risks. Long-term glucocorticoids must not be stopped suddenly.

NSAIDs may reduce pain and stiffness but are not suitable for everyone because of kidney, gastrointestinal, blood-pressure, cardiac and bleeding risks. Infection should be excluded before an intra-articular injection. Ultrasound guidance may improve placement in some joints, but an injection is not a permanent substitute for control of systemic disease.

Disease-specific examples

• Gout: The acute flare is treated with a suitable anti-inflammatory option. Recurrent flares, tophi, stones or selected risks may justify urate-lowering treatment, adjusted to kidney function and a serum-urate target.

• Lupus and vasculitis: Treatment depends on severity and the organ involved. Kidney, brain, lung or major-vessel disease may require urgent multidisciplinary care.

• Osteoarthritis: Education, appropriate exercise, weight management, physical therapy, aids and individual pain treatment are central. An X-ray showing osteoarthritis does not by itself mean joint replacement.

• Fibromyalgia: Graded activity, sleep and psychological support, pain education and selected medicines may be combined. Routine opioids or immunosuppression are not solutions.

Rehabilitation, daily life and surgery

Exercise is tailored to disease activity, joint damage and the individual. Load may be reduced during a flare, but prolonged inactivity promotes muscle loss and reduced function. Physiotherapy, occupational therapy, hand exercises, pacing, orthoses and assistive devices may be part of care. The World Health Organization package for musculoskeletal rehabilitation supports structured interventions that improve function and participation.

Stopping smoking, balanced nutrition, an appropriate weight, sleep, oral health and cardiovascular-risk control matter. “Detox” regimens and unproven stem-cell, ozone or herbal products should not replace disease-modifying therapy; supplements can interact with prescribed medicines.

Joint replacement, tendon repair or spinal surgery may be considered when pain and disability persist despite appropriate non-surgical care. The rheumatologist, surgeon and anaesthesia team should jointly plan infection and clot prevention and the timing of medicines around surgery.

Vaccination, infection and reproductive safety

Vaccination records should be reviewed before immunosuppressive treatment. Timing differs for live and non-live vaccines and for different medicines. The CDC guidance on vaccination in altered immunocompetence recommends considering both safety and likely effectiveness in relation to immune status and treatment timing. Report fever, cough, urinary symptoms, a shingles-like rash or an open wound; do not self-start antibiotics.

Pregnancy and breastfeeding are best planned when disease is stable and medicines are compatible. Some rheumatology medicines must be stopped well in advance; others may be continued to maintain control. Effects on reproduction need separate consideration for women and men. Contraception, pregnancy, breastfeeding and the post-partum flare plan should be agreed in writing with rheumatology and obstetric teams.

Choosing a team and centre in Türkiye

Depending on the condition, an adult or paediatric rheumatologist may work with internal medicine, physical medicine and rehabilitation, dermatology, ophthalmology, respiratory medicine, nephrology, neurology, cardiology, infectious diseases, orthopaedics, obstetrics, radiology, pathology and physiotherapy. Multidisciplinary review is especially valuable in lupus, vasculitis, interstitial lung disease and pregnancy.

Check whether the provider and facilitator appear on the authorised lists of the Ministry of Health of the Republic of Türkiye. Clinicly can assist with specialist matching, record transfer, appointments, interpreting and travel and follow-up coordination. Ask about relevant rheumatology experience, laboratory and imaging access, infusion safety, emergency support and communication after you return home.

International patient pathway

1. Prepare records: Send the symptom timeline, medicines, vaccinations, infection history, test reports and images.

2. Specialist pre-assessment: Clarify urgency, missing investigations, fitness to travel and the required team.

3. Written programme and quotation: Separate consultations, laboratory tests, imaging, joint-fluid analysis, infusions, rehabilitation and follow-up.

4. In-person verification: The preliminary plan may change after examination and new results; benefits, risks and alternatives are discussed.

5. Treatment and education: Receive a written medicine schedule, injection or cold-chain instructions, and infection and flare plans.

6. Handover home: Obtain a diagnostic summary, generic medicine names, results, prescriptions, monitoring intervals and a note for the local rheumatologist.

Clinicly Health Tourism can coordinate healthcare-provider communication, interpreting, transfers, accommodation and follow-up throughout these steps.

What should the quotation specify?

Travel and return planning

Active infection, a severe flare, new organ involvement, uncontrolled pain or recent surgery may change fitness to fly. On a long journey, clot risk is considered with disease activity, immobility, pregnancy, previous thrombosis and medicines. Carry medicines in original packaging in hand luggage with prescriptions and a clinician’s letter. Check manufacturer and airline instructions for products requiring a cold chain.

Before leaving Türkiye, establish who receives pending results, who renews medicine, where monitoring will occur and where to seek urgent care. The CDC guide to medical tourism recommends carrying medical records and arranging complication and follow-up care before travel.

Frequently Asked Questions

1. Does a positive rheumatoid factor confirm rheumatoid arthritis?

No. It can be positive in healthy people and other conditions. Symptoms, examination, anti-CCP, inflammation markers and imaging are interpreted together.

2. Does a positive ANA mean I have lupus?

No. ANA is sensitive but not specific. Lupus is diagnosed from the clinical pattern and more specific blood and urine findings.

3. Is all joint pain inflammatory rheumatism?

No. Mechanical problems, injury, infection, crystals, nerve pain and fibromyalgia can all cause pain around joints.

4. Is a biologic always the strongest and best option?

Not for everyone. It is chosen at the appropriate stage after considering disease type, previous response, infection and other risks.

5. Can I stop medicine when I feel well?

Not without speaking to the prescriber. Disease can remain active without obvious symptoms, and abrupt withdrawal may cause a flare or glucocorticoid withdrawal.

6. Can I be vaccinated while taking rheumatology medicines?

Many patients can receive appropriate vaccines, but live-vaccine safety and the timing of all vaccines depend on the medicine and immune status.

7. Is pregnancy possible with rheumatic disease?

Planned pregnancy is possible for many patients. Disease activity and medicines should be reviewed in advance, and harmful medicines changed with adequate lead time.

8. Will exercise damage my joints?

Appropriately selected exercise usually supports strength and function. The plan is modified for an active flare, major damage or heart and lung involvement.

9. Is a joint injection a permanent solution?

Not always. It may reduce inflammation in one joint, but infection must be excluded and any systemic disease still requires appropriate treatment.

10. What records should I take home?

Take the diagnostic and consultation summary, test reports and images, generic medicine names and doses, infusion record, vaccination and infection plan, warning signs and monitoring schedule.

Conclusion

Safe treatment of rheumatic diseases in Türkiye depends on correct classification, assessment of organ and infection risks, target-based monitored treatment, rehabilitation and uninterrupted follow-up. Clinicly Health Tourism can support record, provider, interpreting, travel and follow-up coordination; final medical decisions remain with the licensed clinicians who assess the patient.